V116 Elicits Noninferiority Immune Response Compared with PP

Merck presented results from the STRIDE-10 phase 3 trial at the 34th European Society of Clinical Microbiology and Infectious Diseases in Barcelona, Spain.

Related Keywords

Barcelona , Comunidad Autonoma De Cataluna , Spain , South Africa , Cape Town , Western Cape , Bernard Chantal , European Society Of Clinical Microbiology , Meeting Of The International Society Pneumonia , European Society , Clinical Microbiology , Infectious Diseases , International Society , Pneumococcal Disease , Pharmacy Times , Announces Positive Data , Positive Immunogenicity , Vaccine Has Non Inferior Immune Response Compared , Priority Review , New Biologics License Application , Breakthrough Designation , Investigational Pneumococcal Conjugate Vaccine ,